---
title: 'Positional proteomics: is the technology ready to study clinical cohorts?'
date: '2023-10-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37869791/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231023180908&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Positional proteomics provides proteome-wide information
  on protein termini and their modifications, uniquely enabling unambiguous identification
  of site-specific, limited proteolysis. Such proteolytic cleavage irreversibly modifies
  protein sequences resulting in new proteoforms with distinct protease-generated
  neo-N and C-termini and altered localization, activity. Mis regulated proteolysis
  is implicated in a wide variety of human diseases. Protein termini, therefore, constitute
  ...'
disable_comments: true
---
INTRODUCTION: Positional proteomics provides proteome-wide information on protein termini and their modifications, uniquely enabling unambiguous identification of site-specific, limited proteolysis. Such proteolytic cleavage irreversibly modifies protein sequences resulting in new proteoforms with distinct protease-generated neo-N and C-termini and altered localization, activity. Mis regulated proteolysis is implicated in a wide variety of human diseases. Protein termini, therefore, constitute ...